RimeTOOLS3 to accelerate phage research

Rime Bioinformatics' RimeTOOLS3 deciphers 60-80% of phage DNA with unmatched precision and speed, aiding in the rapid development of phage-based products and supporting the transition from antibiotics to phage therapy. ISO:9001 and GxP compliant.

RimeTOOLS3 offers unparalleled precision and efficiency in phage genome annotation, deciphering 60-80% of phage DNA at 100 times the precision and 6 times the speed of conventional methods. Compliant with ISO:9001, GxP, and NCBI standards, our technology reduces development time and costs, promoting safer and more effective phage therapy. By collaborating with leading startups, we facilitate the industry’s shift from antibiotics to innovative antibacterial solutions.

  • Infection prevention
  • Antimicrobial stewardship
  • Antimicrobial compound/strategy
  • Microbial diagnostics
  • Removal antibiotics/bacteria

  • Bacteria
  • Viruses
  • Fungi
  • Yeasts
  • Parasites

  • Human
  • Veterinary
  • AgriFood
  • Environmental
  • Other

Development stage:
  • Market entry
  • Research
  • Development
  • Validation
  • Marketed product

  • Company
  • Academia
  • Institute
  • NGO
  • Government

  • License
  • Co-develop
  • Outsource
  • Joint Venture
  • Sell

Funding organisation:
  • OTHER / NA
  • CARB-X
  • FIND

Infectious disease area:
  • UTI
  • STI
  • BSI
  • RTI
  • GII
  • SSTI
  • CNSI
  • IAI
  • SSI

Geographic origin:
  • Eurasia
  • North America
  • South America
  • Africa
  • Oceania

Based in Paris, Rime Bioinformatics specializes in advanced bioinformatics solutions to fight antibiotic resistance, a major public health challenge. We focus on the development and analysis of therapeutic bacteriophages (phages), natural viruses that target bacteria. Our services ensure the safe and effective use of phages in various sectors, including human and animal health, agriculture, food safety, and cosmetics. By partnering with leaders in phage therapy field, we are driving the shift from antibiotics to innovative antibacterial solutions.

Rime Bioinformatics, with RimeTOOLS3, excels in phage genome annotation. Our services also include bacterial genome characterization and high-precision prophage detection for phage production. We manage phage therapy projects by partnering with world-class experts, guiding partners from lab to final product with comprehensive regulatory and market advice.

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed